Factors driving the growth of this market include high incidence and broad economic burden of autoimmune diseases, increasing healthcare expenditure, and growing access to medical insurance in the US.
According to a new market research ” Autoimmune Disease Diagnosis Market by Products (Consumables, Assay Kits, Instruments, Services), Test Type (Inflammatory Markers, Autoantibodies), Disease (RA, SLE, Thyroiditis, Scleroderma), End Users (Hospitals, Clinical Labs) – Global Forecast to 2022 “ , published by Marketsand Market , the market is expected to reach USD 4.73 Billion by 2022 from USD 3.09 Billion in 2017, and a CAGR of 8.9%.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174826519
Key players in the Autoimmune Disease Diagnosis Market include Thermo Fisher Scientific. (US), Danaher (US), HYCOR Biomedical (US), Siemens (Germany), Bio-Rad Laboratories. (US), and Abbott (US).
Consumables and assay kits are estimated for the largest share of the market in 2017
Routine laboratory tests are estimated to be the largest share of the market during the diagnosis of autoimmune disease, the autoimmune disease diagnostics, the inflammatory markers, autoantibodies and immunologic tests, and other tests. In 2017, the autoimmune Disease Diagnosis Market is the largest segment of the world. The increasing incidence of autoimmune diseases, with increasing adoption of routine laboratory tests for a variety of diseases, is driving the growth of this end-user segment.
The rheumatoid arthritis segment is expected to dominate the market in 2017
By disease, the market is segmented into systemic lupus erythematosus, rheumatoid arthritis, Sjogren’s syndrome, thyroiditis, scleroderma, and other diseases. The rheumatoid disease is expected to account for the largest share of the global autoimmune disease in 2017. The growth of this segment is primarily driven by the rising incidences of the disease.
Clinical laboratories are estimated to be the largest share of the market during the forecast period
On the basis of end user, the Autoimmune Disease Diagnosis Market is categorized into clinical laboratories, hospitals, and other end users. The clinical laboratories segment is estimated to account for the largest share of the global Autoimmune Disease Diagnosis Market during the forecast period. The heavy burden of autoimmune diseases, along with the accessibility of the diagnosis and treatment of patients in clinical trials, is a key factor in the growth of this end-user segment.
North America is the largest market share of the market
Based on region, the Autoimmune Disease Diagnosis Market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to dominate the Autoimmune Disease Diagnosis Market in 2017. The diagnosis of autoimmune diseases and the diagnosis of autoimmune diseases. region as compared to other regions.
